Skip to main content
Signal8

Hemostemix Inc. (HMTXF)

Hemostemix, Inc. is a clinical-stage biotechnology company, which is focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. The firm's, ACP-01, lead clinical stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. The company was founded by Roger Bergersen and Thomas A. Smeenk in 2006 and is headquartered in Calgary, Canada.

Sector: Biotechnology

Industry: Biotechnology

Hemostemix Inc. logo

Hemostemix Inc.

OTC:HMTXFHealthcare
-31.71%$0.0239
CLOSED
Mkt Cap$5.05M
EV$7.05M
Float168.41M
O/S211.44M
VOL79K sh
$ Vol$2K
RVOL1.85×
Inst Own-
SI<0.1%
Net Cash/Sh-$0.01
Dilution
Hemostemix Inc. logoOTC:HMTXFClosed$0.0239-31.71%
Financials Summary
Revenue$0
Net Income-$3.3M
Total Assets$592K
Free Cash Flow-$3.17M
Debt & Equity
Total Debt$2.52M
Total Equity-$3.48M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:20Reverse split
    Dec 30, 202020 shares → 1
Balance Sheet Details
Assets$592K
Liabilities$4.07M
Accounts Receivable$46K
Accounts Payable$1.21M
Inventory$0
PP&E (Net)$26
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0
YoY Growth-------------
Cost of Revenue$32$49$156$347$771$2K$1K$0$0$0$26K$0$0
Gross Profit-$32-$49-$156-$347-$771-$2K-$1K$0$0$0-$26K$0$0
Gross Margin-------------
Research and Development$1.74M$2K$269K$436K$126K$455K$1.65M$1.58M$42K$580K$1.04M$1.1M$200K
Selling, General, and Administrative$1.8M$1.38M$1.36M$2.72M$4.53M$4.77M$1.64M$2.91M$1.93M$1.61M$1.72M$1.68M$855K
Other$405K$20$79-$869K$770$5K$1K$0$0$0$0$0$0
Total Operating Expenses$3.94M$1.39M$1.63M$2.29M$4.66M$5.23M$3.29M$4.5M$1.97M$2.6M$2.79M$2.63M$1.07M
Operating Income (EBIT)-$3.94M-$1.39M-$1.63M-$2.29M-$4.67M-$3.41M-$3.29M-$4.65M-$1.97M-$2.6M-$2.76M-$2.63M-$1.05M
Operating Margin-------------
Interest Expense$392K$438K$385K$245K$7K$74K$73K$0$797K$2K$0$0$0
Interest Income$0$0$0$0$51K$0$0$0$0$0$0$0$0
Other Income (Expense)$643K-$446K-$118K-$1.03M$87K-$2.02M-$122K$169K-$491K-$99K$30K-$400K-$1K
Income Before Tax (EBT)-$3.3M-$1.83M-$1.75M-$3.32M-$4.58M-$5.44M-$3.41M-$4.33M-$2.46M-$1.93M-$2.77M-$3.03M-$1.06M
Income Tax Expense$0$0$0$341K-$179K$0$0$4K-$42K-$7K$16K$7K$18K
Net Income-$3.3M-$1.83M-$1.75M-$3.66M-$4.4M-$5.44M-$3.41M-$4.33M-$2.75M-$2.65M-$2.79M-$3.03M-$1.08M
Net Income Margin-------------
Supplementary Data
EPS-0.03-0.03-0.03-0.07-0.11-0.24-0.32-0.41-0.56-1.12-1.13-1.39-0.50
Diluted EPS-0.03-0.03-0.03-0.07-0.11-0.24-0.32-0.41-0.56-1.12-1.13-1.39-0.50
Weighted Average OS163.44M93.44M82.50M69.98M57.45M32.24M15.04M14.93M6.98M3.37M3.52M3.12M3.05M
EBITDA-$3.94M-$1.39M-$1.63M-$2.29M-$1.94M-$3.41M-$3.25M$69-$1.94M-$1.8M-$2.76M-$3M-$1.04M
EBITDA Margin-------------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$477K$494K$109K$95K$154K$181K$17K$1.03M$2.77M$24K$355K$2.31M$246K
Short-Term Investments$42K$0$0$0$0$0$0$0$878K$0$0$0$0
Cash and Short-Term Investments$519K$494K$109K$95K$154K$181K$17K$1.03M$3.65M$24K$355K$2.31M$246K
Accounts Receivable$46K$161K$18K$97K$240K$1.44M$9K$134K$0$0$0$132K$0
Inventory$0$0$0$0-$240K$0-$9K-$62K-$43K-$52K-$56K-$187K-$169K
Other Current Assets$3$0$0$0$240K$0$53K$0$0$0$0$135K$169K
Total Current Assets$592K$694K$220K$325K$394K$1.62M$70K$1.16M$3.71M$88K$424K$2.62M$435K
Long-Term Assets
Property, Plant & Equipment Net$26$58$128$284$631$1K$3K$0$0$71K$97K$107K$106K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$0$0$0$0$37K$31K$31K
Total Long-Term Assets$27$59$129$285$631$1K$3K$0$0$71K$134K$138K$137K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$592K$694K$220K$326K$394K$1.63M$73K$1.16M$3.71M$159K$558K$2.76M$572K
Liabilities
Current Liabilities
Accounts Payable$1.21M$1.94M$1.84M$1.83M$2.32M$1.38M$728K$549K$244K$667K$287K$251K$44K
Short-Term Debt$0$0$0$0$0$123K$1.45M$0$0$755K$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$3K$5K$24K$31K
Current Unearned Revenue$0$0$0$0$0$0-$731K$0$0$399K$0$0$0
Other Current Liabilities-$987$1.35M$1.52M$2K$738K$889K$1.46M$273K$45K$546K$5K$24K$120K
Total Current Liabilities$1.21M$1.94M$2.01M$1.83M$3.06M$2.4M$2.9M$822K$325K$2.36M$436K$386K$170K
Long-Term Liabilities
Long-Term Debt$2.52M$3.46M$3.03M$2.89M$1.04M$0$0$0$0$219K$0$0$0
Long-Term Unearned Revenue$0$0$0-$341K$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$341K$341K$341K$341K$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$341K$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$2.86M$3.8M$3.37M$3.23M$1.04M$0$0$0$0$219K$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$4.07M$5.74M$5.38M$5.06M$4.09M$2.4M$2.9M$822K$325K$2.58M$436K$386K$170K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$33.84M$30.74M$29.74M$28.76M$27.07M$26.53M$21.72M$21.72M$21.52M$15.47M$15.37M$14.8M$10.17M
Retained Earnings-$49.38M-$46.12M-$44.29M-$42.54M-$38.87M-$34.47M-$29.03M-$25.62M-$21.29M-$18.54M-$15.89M-$13.1M-$10.07M
Comprehensive Income & Other$1.79M$1.08M$1.04M$1.87M$1.06M$1.08M$308K$2.2M$2.26M$51K$0$0$0
Other Stockholders' Equity$12.06M$10.33M$9.39M$9.04M$8.1M$7.17M$4.48M$4.24M$3.16M$645K$643K$673K$297K
Total Equity-$3.48M-$5.04M-$5.16M-$4.74M-$3.7M-$769K-$2.83M$341K$3.39M-$2.42M$122K$2.37M$402K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$592K$694K$220K$326K$394K$1.63M$73K$1.16M$3.71M$159K$558K$2.76M$572K
Supplementary Data
Total Debt$2.52M$3.46M$3.03M$2.89M$1.04M$123K$1.45M$0$0$974K$0$0$0
Net Debt$2.04M$2.96M$2.92M$2.79M$884K-$58K$1.43M-$1.03M-$2.77M$949K-$355K-$2.31M-$246K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income-$3.3M-$1.83M-$1.75M-$3.66M-$4.4M-$5.44M-$3.41M-$4.33M-$2.42M-$2.65M-$2.79M-$3.03M-$1.08M
Depreciation & Amortization$32$70$156$347$771$2K$1K$4.5M$27K$27K$26K$22K$18K
Deferred Income Tax$0$0$0$341K-$179K$132K$0$0-$42K-$18K$0$0$0
Stock-Based Compensation$793K$232K$105K$125K$253K$1.63M$233K$1.15M$318K$0$0$344K$297K
Changes in Working Capital:
  Accounts Receivable$114K-$143K$80K$143K$1.2M-$1.39M$81K-$71K$50K$43K$162K-$19K-$49K
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$0$0$0$0$0$0$0$497K-$277K$0$0$0$0
  Other Working Capital-$359K-$19K$309K-$1.34M$767K$813K$637K$807K$46K$630K$120K-$56K-$28K
Total Working Capital Change-$245K-$162K$388K-$1.19M$1.97M-$578K$718K$1.3M-$231K$673K$282K$116K-$12K
Other Non-Cash Items-$422K$431K$264K$121K-$80K$74K$73K-$4.5M$94K$66K-$110K$357K$65K
Net Cash from Operating-$3.17M-$1.33M-$994K-$4.27M-$2.43M-$4.18M-$2.38M-$1.88M-$2.25M-$1.88M-$2.48M-$2.19M-$775K
Investing Activities
Capital Expenditures$0$0$0$0$0$0-$4K$0$0-$1K-$16K-$23K-$35K
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$102K$0$0$0$0$0$0$0-$878K$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$120K$0$0$0$0$0$0$0$0
Net Cash from Investing-$102K$0$0$0$120K$0-$4K$0-$878K-$1K-$16K-$23K-$35K
Financing Activities
Debt Repaid$350K---$1.93M-$1.63M$1.29M-$1.37M--$875K-$1.15M---
Common Stock Issuance$3.61M$1.72M$1.05M$2.42M$588K$6.14M$0$141K$4.11M$53K$454K$4.28M$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0-$46K-$129K-$50K-$495K$1.37M$141K$14K$53K$85K$10K$931K
Net Cash from Financing$3.26M$1.72M$1.01M$4.21M$2.29M$4.35M$1.37M$141K$5M$1.55M$539K$4.29M$931K
Forex Effect$23K$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$6K$385K$14K-$59K-$27K$164K-$1.01M-$1.74M$2.75M-$330K-$1.96M$2.07M$120K
Supplementary Data
Operating Cash Flow-$3.17M-$1.33M-$994K-$4.27M-$2.43M-$4.18M-$2.38M-$1.88M-$2.25M-$1.88M-$2.48M-$2.19M-$775K
Capital Expenditure$0$0$0$0$0$0-$4K$0$0-$1K-$16K-$23K-$35K
Free Cash Flow-$3.17M-$1.33M-$994K-$4.27M-$2.43M-$4.18M-$2.39M-$1.88M-$2.25M-$1.88M-$2.5M-$2.22M-$810K
Cash at Beginning$471K$109K$95K$154K$181K$17K$1.03M$2.77M$24K$355K$2.31M$246K$126K
Cash at End$477K$494K$109K$95K$154K$181K$17K$1.03M$2.77M$24K$355K$2.31M$246K